Abstract
Budd-Chiari syndrome (BCS caused by hepatic venous outflow obstruction due to occlusion of hepatic vein and/or the inferior vena cava (IVC consists of a variety of clinical manifestations such as abdominal pain, hepatomegaly, ascite associated with acute or chronic liver dysfunction and portal hypertension. A large number of therapies have been introduced for BCS, both medical (including diuretics, thrombolytics, and anticoagulants and surgical (such as peritoneovenous shunt, direct correction of the venous obstruction, decompressive portosystemic venous shunt, and in end-stage liver disease, orthotopic liver transplantation. More recently percutaneous transluminal angioplasty (PTA has been used to relieve the obstruction. PTA differs from surgery in that it can be used repeatedly because it is less invasive and safer. Possible complicati- ons of PTA include stent migration, occlusion due to thrombus formation or neointimal hyperplasia, pulmonary embolism, hemorrage and infection. We experienced one case with complication of stent migration into right ventricle after PTA for BCS. (Korean Circulation J 2000;30(7 :885-889
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
